57489-79-9 Usage
Uses
Used in Pharmaceutical Industry:
Pyrazolo[1,5-a]pyrimidin-7-ol is used as a drug candidate for the treatment of various conditions, primarily cancer and inflammation. Its unique structure and high affinity for biological targets make it a valuable compound in the development of novel therapeutic agents.
Used in Drug Discovery:
Pyrazolo[1,5-a]pyrimidin-7-ol is utilized as a scaffold in the design and synthesis of new pharmaceutical compounds. Its ability to target specific enzymes and receptors allows researchers to explore its potential in treating a wide range of diseases and disorders.
Used in Targeting Specific Enzymes and Receptors:
Pyrazolo[1,5-a]pyrimidin-7-ol is employed as a molecule with high affinity for various biological targets, making it a promising candidate for the development of drugs that can modulate the activity of specific enzymes and receptors involved in disease processes.
Used in Preclinical Studies:
Pyrazolo[1,5-a]pyrimidin-7-ol is used in preclinical research to evaluate its efficacy and safety as a potential drug candidate. The promising results obtained in these studies contribute to its significance in drug development and the advancement of new therapeutic options.
Check Digit Verification of cas no
The CAS Registry Mumber 57489-79-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,4,8 and 9 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 57489-79:
(7*5)+(6*7)+(5*4)+(4*8)+(3*9)+(2*7)+(1*9)=179
179 % 10 = 9
So 57489-79-9 is a valid CAS Registry Number.
InChI:InChI=1/C6H5N3O/c10-6-2-3-7-5-1-4-8-9(5)6/h1-4,8H
57489-79-9Relevant academic research and scientific papers
HETEROCYCLIC COMPOUNDS AND USES THEREOF
-
Page/Page column 79-80, (2012/05/21)
Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.
